Skip to main content

Active Pharmaceutical Ingredient (API) Market Competitive Landscape and Application Development Analysis to 2027

Press release   •   Apr 10, 2019 15:19 IST

The Active Pharmaceutical Ingredient (API) Market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. Further, the report also covers key players profiling with detailed SWOT analysis, financial facts and key developments of products/service from the past three years.

The Active Pharmaceutical Ingredient (API) market is anticipated to grow in the forecast period owing to driving factors such as growing prevalence of chronic diseases, advancements in technology for API production, rising adoption of generic medicine, increasing focus on personalize medicine and increasing investments in the pharmaceutical sector. The market is subject to various stringent laws and regulations that deal with patenting, testing, safety, efficacy and marketing and unfavorable drug price control policies across various countries hinders with the market growth. 

Get PDF sample copy: https://www.theinsightpartners.com/sample/TIPRE00003407/

The pharmaceutical drugs are made up of two core components: the API, which is the vital ingredient and the excipients, are the substances which helps in delivering the API to the human system. The pharmaceuticals companies use certain standards to control and regulate the strength of the API in each drug. However, the standard varies from one brand to another. Many pharmaceutical companies located in the United States and Europe have started outsourcing the API manufacturing in order to reduce the costs on expensive equipment, employees and infrastructure.

The List of Companies

1. Teva Pharmaceutical Industries Ltd.
2. AbbVie, Inc.
3. Boehringer Ingelheim International GmbH
4. Cipla, Inc.
5. Merck & Co., Inc.
6. Bristol-Myers Squibb Company
7. Albemarle Corporation
8. Mylan N.V.
9. Aurobindo Pharma
10. Sun Pharmaceutical Industries Ltd.

The global active pharmaceutical ingredient (API) market is segmented on the basis of type of synthesis and therapeutic application. The active pharmaceutical ingredient (API) market, based on type of synthesis is segmented into Biotech and Synthetic. Based on therapeutic application, the market is segmented as cardiology, oncology, CNS and neurology, orthopaedic, endocrinology, pulmonology, gastroenterology, nephrology, ophthalmology and others. 

Inquire for discount: https://www.theinsightpartners.com/discount/TIPRE00003407/

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global active pharmaceutical ingredient (API) market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The active pharmaceutical ingredient (API) market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting active pharmaceutical ingredient (API) market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the active pharmaceutical ingredient (API) market in these regions.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, Healthcare and Telecommunication industries.

Comments (0)

Add comment

Comment

By submitting the comment you agree that your personal data will be processed according to Mynewsdesk's Privacy Policy.